HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $17 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a 'Buy' rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a price target of $17.
August 01, 2023 | 10:19 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tyra Biosciences' stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $17.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $17 also indicates their confidence in the company's potential. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100